Pre-B-cell colony enhancing factor (PBEF) increases endothelial permeability in hypoxia/re-oxygenation model

Area of Science:

• Endothelial cell biology
• Hypoxia/re-oxygenation injury
• Molecular mechanisms of vascular permeability

Background:

• Endothelial barrier dysfunction is critical in hypoxia/re-oxygenation injury.
• The role of PBEF (also known as Visfatin) in regulating endothelial permeability requires further elucidation.
• Understanding the molecular pathways involved is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the relationship between PBEF, VEGF, and p-MLC in endothelial cells under hypoxia/re-oxygenation.
• To elucidate the mechanism by which PBEF influences endothelial cell permeability.

Main Methods:

• Establishment of a hypoxia/re-oxygenation model in human umbilical vein endothelial cells (HUVECs).
• Synthesis and application of PBEF siRNA to knockdown PBEF expression.
• Quantitative analysis of PBEF, VEGF, and p-MLC expression using RT-PCR and Western blot at various time points.

Main Results:

• PBEF siRNA effectively reduced PBEF mRNA and protein expression in HUVECs.
• Hypoxia/re-oxygenation significantly upregulated PBEF expression, peaking at 9 hours.
• Knockdown of PBEF led to a significant decrease in VEGF and p-MLC expression under hypoxia/re-oxygenation conditions.

Conclusions:

• PBEF plays a significant role in endothelial cell response to hypoxia/re-oxygenation.
• PBEF may increase endothelial permeability by modulating VEGF expression and MLC phosphorylation.
• Targeting PBEF could be a potential therapeutic approach for conditions involving endothelial barrier dysfunction.